PortfoliosLab logoPortfoliosLab logo
NLSI vs. IHE
Performance
Return for Risk
Drawdowns
Volatility
Dividends

Performance

NLSI vs. IHE - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Neos Long/Short Equity Income ETF (NLSI) and iShares U.S. Pharmaceuticals ETF (IHE). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, NLSI achieves a 6.57% return, which is significantly lower than IHE's 19.23% return.


NLSI

1D
0.06%
1M
5.39%
6M
6.88%
YTD
6.57%
1Y
3Y*
5Y*
10Y*

IHE

1D
-1.67%
1M
6.40%
6M
19.24%
YTD
19.23%
1Y
52.26%
3Y*
22.13%
5Y*
11.73%
10Y*
8.82%
*Multi-year figures are annualized to reflect compound growth (CAGR)

NLSI vs. IHE - Yearly Performance Comparison


Correlation

The correlation between NLSI and IHE is -0.11, meaning they tend to move in opposite directions. This is especially valuable for risk management - when one declines, the other has historically tended to hold steady or rise.


Correlation
Correlation (All Time)
Calculated using the full available price history since Dec 10, 2025

-0.11

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

NLSI vs. IHE — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NLSI

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.


IHE
IHE Risk / Return Rank: 9393
Overall Rank
IHE Sharpe Ratio Rank: 9494
Sharpe Ratio Rank
IHE Sortino Ratio Rank: 9595
Sortino Ratio Rank
IHE Omega Ratio Rank: 9191
Omega Ratio Rank
IHE Calmar Ratio Rank: 9595
Calmar Ratio Rank
IHE Martin Ratio Rank: 9393
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

NLSI vs. IHE - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Neos Long/Short Equity Income ETF (NLSI) and iShares U.S. Pharmaceuticals ETF (IHE). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


NLSIIHEDifference
Sharpe ratioReturn per unit of total volatility

Sortino ratioReturn per unit of downside risk

Omega ratioGain probability vs. loss probability

1.48

Calmar ratioReturn relative to maximum drawdown

6.06

Martin ratioReturn relative to average drawdown

18.58

NLSI vs. IHE - Sharpe Ratio Comparison


Loading charts...

Drawdowns

NLSI vs. IHE - Drawdown Comparison

The maximum NLSI drawdown since its inception was -13.82%, smaller than the maximum IHE drawdown of -38.20%. Use the drawdown chart below to compare losses from any high point for NLSI and IHE.


Loading charts...

Drawdown Indicators


NLSIIHEDifference

Max Drawdown

Largest peak-to-trough decline

-13.82%

-38.20%

+24.38%

Max Drawdown (1Y)

Largest decline over 1 year

-8.47%

Max Drawdown (3Y)

Largest decline over 3 years

-15.92%

Max Drawdown (5Y)

Largest decline over 5 years

-16.03%

Max Drawdown (10Y)

Largest decline over 10 years

-29.59%

Current Drawdown

Current decline from peak

-1.74%

-2.81%

+1.07%

Average Drawdown

Average peak-to-trough decline

-5.90%

-7.88%

+1.98%

Ulcer Index

Depth and duration of drawdowns from previous peaks

2.76%

Volatility

NLSI vs. IHE - Volatility Comparison


Loading charts...

Volatility by Period


NLSIIHEDifference

Volatility (1M)

Calculated over the trailing 1-month period

6.73%

Volatility (6M)

Calculated over the trailing 6-month period

13.70%

Volatility (1Y)

Calculated over the trailing 1-year period

19.27%

18.07%

+1.20%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

19.27%

16.48%

+2.79%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

19.27%

18.05%

+1.22%

NLSI vs. IHE - Expense Ratio Comparison

NLSI has a 2.89% expense ratio, which is higher than IHE's 0.38% expense ratio.


Dividends

NLSI vs. IHE - Dividend Comparison

NLSI's dividend yield for the trailing twelve months is around 2.87%, more than IHE's 1.46% yield.


PositionTTM20252024202320222021202020192018201720162015
IHE
iShares U.S. Pharmaceuticals ETF
1.46%1.76%1.73%1.39%2.01%1.49%1.19%1.40%1.25%1.36%0.92%1.93%
NLSI
Neos Long/Short Equity Income ETF
2.87%0.46%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%

Frequently Asked Questions


NLSI and IHE have a correlation of -0.11, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

On fees, IHE is cheaper at 0.38% per year. The better choice depends on whether you care most about return, fees, risk, or income.

IHE is cheaper with a 0.38% expense ratio, compared with 2.89% for NLSI.

NLSI has the higher dividend yield at 2.87%, compared with 1.46% for IHE.

NLSI is categorized as Long-Short, while IHE is Health & Biotech Equities. They also come from different issuers: Neos and iShares. Their fees differ too: 2.89% for NLSI and 0.38% for IHE.

Portfolio Optimizer

Find the right allocation for NLSI and IHE

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer